Human papilloma virus genotype distribution in women with premalignant or malignant lesions of the uterine cervix-Reference-Cited by-同舟云学术

Human papilloma virus genotype distribution in women with premalignant or malignant lesions of the uterine cervix

Published:2021-02-04 Issue:3 Volume:304 Page:751-758
ISSN:0932-0067
Container-title:Archives of Gynecology and Obstetrics
language:en
Short-container-title:Arch Gynecol Obstet

Author:

Stuebs Frederik A.^ORCID,Gass Paul,Dietl Anna K.,Schulmeyer Carla E.,Adler Werner,Geppert Carol,Hartmann Arndt,Knöll Antje,Beckmann Matthias W.,Koch Martin C.

Publisher

Springer Science and Business Media LLC

Subject

Obstetrics and Gynecology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00404-021-05986-z.pdf

Reference34 articles.

1. Barnes B et al (2016) RKI Bericht zum Krebsgeschehen in Deutschland 2016. https://www.krebsdaten.de/Krebs/DE/Content/Publikationen/Krebsgeschehen/Krebsgeschehen_node.html

2. Stuebs FA et al (2019) Accuracy of colposcopy-directed biopsy in detecting early cervical neoplasia: a retrospective study. Arch Gynecol Obstet 299(2):525–532

3. Walboomers JM et al (1999) Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189(1):12–19

4. Siegler E et al (2017) Prevalence and genotype distribution of HPV types in women at risk for cervical neoplasia in Israel. Isr Med Assoc J 19(10):635–639

5. Friebe K et al (2017) The value of partial HPV genotyping after conization of cervical dysplasias. Geburtshilfe Frauenheilkd 77(8):887–893

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Understanding the HPV associated cancers: A comprehensive review;Molecular Biology Reports;2024-06-14

2. Primary results of the AGO-Zervix-1 Study: A prospective, randomized phase III study to compare the effects of paclitaxel and topotecan with those of cisplatin and topotecan in the treatment of patients with recurrent and persistent cervical cancer;Gynecologic Oncology;2024-04

3. Impact of the Corona Pandemic on Cervical Cancer Screening Assessment;In Vivo;2024

4. Cytology and HPV Co-Testing for Detection of Vaginal Intraepithelial Neoplasia: A Retrospective Study;Cancers;2023-09-19

5. Standardized Procedures for Patients with Dysplasia and Other Diseases of the Cervix, Vulva, and Vagina at a Certified Dysplasia Unit Prior to the Introduction of the Organized Cervical Cancer Screening Program;Geburtshilfe und Frauenheilkunde;2023-08